Search Results - "Bouchara, Anais"

3-methylhistidine and clinical outcomes in maintenance haemodialysis patients by Bres, Emilie, Pagan, Cécile, Bouchara, Anaïs, Pastural, Myriam, Granjon, Samuel, Laville, Maurice, Fouque, Denis, Soulage, Christophe O, Koppe, Laetitia

“…BACKGROUNDChronic kidney disease is an important contributor to morbidity and mortality. 3-methylhistidine (3-MH) is the by-product of actin and myosin…”
Get full text

Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients by Bouchara, Anaïs, Yi, Dan, Pastural, Myriam, Granjon, Samuel, Selag, Jean-Christophe, Laville, Maurice, Arkouche, Walid, Pelletier, Solenne, Fouque, Denis, Soulage, Christophe O, Koppe, Laetitia

“…Wasting has been associated with increased cardiovascular and all-cause mortality in chronic kidney disease (CKD). We investigated whether serum…”
Get more information

FP322THE UREMIC TOXIN 3 CARBOXY 4 METHYL 5 PROPYL 2 FURANPROPANOIC ACID (CMPF): PARADOX OF ANEW NUTRITIONAL MARKER IN HAEMODIALYSIS by Luce, Mathilde, Bouchara, Anais, Pastural, Myriam, Granjon, Samuel, Szelag, Jean Christophe, Laville, Maurice, Arkouch, Walid, Fouque, Denis, Soulage, Christophe O, Koppe, Laetitia

Get full text

Natriuretic Peptides as Predictors of Protein-Energy Wasting in Hemodialysis Population by Luce, Mathilde, Bres, Emilie, Yi, Dan, Pastural, Myriam, Granjon, Samuel, Szelag, Jean Christophe, Laville, Maurice, Arkouche, Walid, Bouchara, Anais, Fouque, Denis, Soulage, Christophe O., Koppe, Laetitia

“…Imbalance between anabolism and catabolism is linked to cachexia and protein-energy wasting (PEW), especially in frail populations such as patients with…”
Get full text

Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients? by Luce, Mathilde, Bouchara, Anais, Pastural, Myriam, Granjon, Samuel, Szelag, Jean Christophe, Laville, Maurice, Arkouche, Walid, Fouque, Denis, Soulage, Christophe O, Koppe, Laetitia

“…3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) is a metabolite of furan fatty acid and a marker of fish oil intake. CMPF is described as a protein-bound…”
Get full text

3-methylhistidine and clinical outcomes in maintenance hemodialysis patients by Bres, Emilie, Pagan, Cécile, Bouchara, Anaïs, Pastural, Myriam, Granjon, Samuel, Laville, Maurice, Fouque, Denis, Soulage, Christophe O, Koppe, Laetitia

“…Chronic kidney disease is an important contributor to morbidity and mortality. 3-methylhistidine (3-MH) is the by-product of actin and myosin degradation…”
Get full text

SP351INTEREST OF FREE VITAMIN D IN CKD by Bouchara, Anaïs, Carlier, Marie-Christine, Koppe, Laetitia, Nouvier, Mathilde, Laville, Maurice, Pommier, Bertille, Fouque, Denis, Pelletier, Solenne

Get full text